OTHER PUBLICATIONS & ABSTRACTS
Other Data
Evidence / Other
High Concordance of 70-Gene Recurrence Risk Signature and 80-Gene Molecular Subtyping Signature Between Core Needle Biopsy and Surgical Resection Specimens in Early-Stage Breast Cancer
Publication: J Surg Oncol. 2022;125:596โ602. Authors: Jennifer A. Crozier MD | Julie Barone DO | Pat Whitworth MD |Abraham Cheong MD | Robert Maganini MD | Jose Perez Tamayo MD | Patricia Dauer PhD | Shiyu Wang MS | William Audeh MD | Annuska M. Glas PhD Title: High Read More
Genomic risk classification and whole transcriptome analysis of HR+/HER2- Post-partum breast cancers โ A FLEX sub study
Publication: ESMO Breast 2024 Authors:ย Virginia F. Borges1, Elena Shagisultanova1, Joyce O'Shaughnessy2, Adam Brufsky3, Reshma L. Mahtani4, Kent Hoskins5, Hannah Linden6, Nina D'Abreo7, Sahra Uygun8, Lavanya Samraj8, William Audeh8 University of Colorado Anschutz Medical Campus, Aurora CO 2. Baylor University Medical Center, Dallas, TX 3. University of Pittsburgh Medical Center Read More
Survival Outcomes for Patients With Invasive Lobular Cancer by MammaPrint: Results From the MINDACT Phase III Trial
Publication: European Journal of Cancer 217 (2025) 115222 Authors: O. Metzger Filho, F. Cardoso, C. Poncet, C. Desmedt, S. Linn, J. Wesseling,F. Hilbers, S. Delaloge,ย J.-Y. Pierga, E. Brain, S. Vrijaldenhoven, P.A. Neijenhuisj, E.J.Th Rutgers, M. Piccart, L.J. van โt Veerl, G. Viale Title: Survival outcomes for patients with Read More
FLEX: A Real-World Evidence, Full Transcriptome Study in 30,000 Patients With Early-Stage Breast Cancer
Source: San Antonio Breast Cancer Symposiumยฎ Authors: Robert Maganini, Ellis Levine, Kent Hoskins, Sarah Thayer, Alfredo Santillan, Sung HoLee, Eduardo Dias, Regina Hampton, Eric Brow Title: FLEX: A Real-World Evidence, Full Transcriptome Study in 30,000 Patients With Early-Stage Breast Cancer Background: The advent of subtype-specific treatments, particularly hormone therapies Read More
Incorporating Immunotherapy in the Management of Early-Stage Estrogen Receptor-Positive Breast Cancer
Publication: ESMO Open - Volume 9 - Issue 11 - 2024 1 Authors: G. Nader-Marta, A. G. Waks, S. M. Tolaney, E. L. Mayer Title: Incorporating immunotherapy in the management of early-stage estrogen receptor-positive breast cancer Abstract Immune checkpoint inhibitors (ICI) have been incorporated into standard treatment regimens for Read More
Identification of Racial Disparities (ESMO 2024)
Publication: ESMO 2024 Authors: Sonya Reid, M.D., Jennifer G. Whisenant, Ph.D.; Jennifer Wei, M.D., Ph.D., Harshini Ramaswamy, M.Sc., Nicole Stivers, Ph.D., Andrea Menicucci, Ph.D., William Audeh, M.D., Tuya Pal, M.D. Title: Identification of racial disparities across MammaPrintยฎ and BluePrintยฎ subtypes in HR+HER2- breast cancer Background: Black women in the Read More
Case Report: pCR to NAC + Pembro in High Risk Basal-type BC
Cureus, part of Springer Nature Author: Jiang et al.
Read More
